| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
17,070,000 |
| Market
Cap: |
92.01(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.39 - $5.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeuBase Therapeutics is a pre-clinical-stage biopharmaceutical company. Co. is developing a modular peptide-nucleic acid antisense oligo (PATrOL™) platform to address genetic diseases. Co.'s programs are: NT0100, which is a PATrOL™-enabled therapeutic program being developed to target the mutant expansion in the Huntington's disease messenger ribonucleic acid; NT0200, which is a PATrOL™-enabled therapeutic program being developed to target the mutant expansion in the myotonic dystrophy type 1 disease messenger ribonucleic acid; and NT-0300, which is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
61,076 |
61,076 |
| Total Buy Value |
$0 |
$0 |
$59,732 |
$59,732 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
489,520 |
489,520 |
| Total Sell Value |
$0 |
$0 |
$712,352 |
$712,352 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
6 |
6 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mann William Roland |
COO |
• – – |
2021-04-26 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2020-12-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,547,639 |
1,273,819 |
|
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2020-11-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,273,819 |
2,547,639 |
|
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2020-11-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,547,639 |
2,547,639 |
|
- |
|
| Lipizzaner Llc |
10% Owner |
– – • |
2020-06-09 |
4 |
B |
$7.73 |
$9,861 |
D/D |
1,275 |
12,525 |
2.37 |
- |
|
| Lipizzaner Llc |
10% Owner |
– – • |
2020-05-21 |
4 |
B |
$8.09 |
$10,111 |
D/D |
1,250 |
11,250 |
2.37 |
- |
|
| Backenroth Samuel |
CFO, Treasurer & Secretary |
• – – |
2020-04-30 |
4 |
B |
$6.00 |
$6,000 |
D/D |
1,000 |
11,630 |
2.74 |
- |
|
| Lipizzaner Llc |
10% Owner |
– – • |
2020-04-30 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
10,000 |
2.45 |
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2020-04-30 |
4 |
B |
$6.00 |
$60,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Richman Eric I |
Director |
– • – |
2020-04-30 |
4 |
B |
$6.00 |
$49,998 |
D/D |
8,333 |
36,080 |
2.39 |
- |
|
| Richman Eric I |
Director |
– • – |
2020-04-30 |
4 |
B |
$6.00 |
$15,000 |
I/I |
2,500 |
27,747 |
2.1 |
- |
|
| Richman Eric I |
Director |
– • – |
2019-07-12 |
4 |
A |
$0.00 |
$0 |
I/I |
25,247 |
25,247 |
|
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2019-07-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,547,639 |
2,547,639 |
|
- |
|
| Hirschman Orin |
Director |
– • – |
2017-04-10 |
4/A |
B |
$0.70 |
$120,000 |
I/I |
171,429 |
1,678,177 |
2.1 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2017-04-10 |
4 |
B |
$0.70 |
$100,001 |
D/D |
142,858 |
1,067,898 |
2.81 |
- |
|
| Backenroth Samuel |
Chief Financial Officer |
• – – |
2017-04-10 |
4 |
B |
$0.70 |
$50,000 |
D/D |
71,429 |
212,596 |
2.74 |
- |
|
| Hirschman Orin |
Director |
– • – |
2017-04-10 |
4 |
B |
$0.70 |
$100,001 |
I/I |
142,858 |
1,649,605 |
2.1 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-07-18 |
4 |
A |
$0.00 |
$0 |
I/I |
497,859 |
1,195,724 |
|
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-06-20 |
4 |
B |
$2.71 |
$25,000 |
D/D |
8,786 |
925,040 |
2.81 |
- |
|
| Backenroth Samuel |
Chief Financial Officer |
• – – |
2016-06-20 |
4 |
B |
$2.71 |
$6,997 |
D/D |
2,468 |
141,167 |
2.74 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
B |
$3.09 |
$11,447 |
D/D |
3,682 |
916,254 |
2.81 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-05-24 |
4 |
B |
$3.06 |
$23,178 |
D/D |
7,503 |
912,572 |
2.81 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-05-23 |
4 |
B |
$3.11 |
$65,199 |
D/D |
20,565 |
905,069 |
2.81 |
- |
|
| Backenroth Samuel |
Chief Financial Officer |
• – – |
2016-05-23 |
4 |
B |
$3.11 |
$7,926 |
D/D |
2,500 |
138,699 |
2.74 |
- |
|
| Slakter Jason Scott |
Chief Executive Officer |
• • – |
2016-04-11 |
4 |
B |
$3.35 |
$20,938 |
D/D |
6,250 |
884,504 |
2.81 |
- |
|
84 Records found
|
|
Page 2 of 4 |
|
|
